Cardiovascular Disease in HIV Patients: A Comprehensive Overview

For decades, human immunodeficiency virus (HIV) was considered primarily an immunological threat. However, with advancements in antiretroviral therapy (ART) extending the lifespan of individuals living with HIV, cardiovascular disease (CVD) has emerged as a significant and growing concern. This article provides a comprehensive review of the relationship between HIV and CVD, exploring the underlying mechanisms, clinical manifestations, diagnostic approaches, and treatment strategies.

The Rising Prevalence of CVD in HIV

The prevalence of cardiac involvement in individuals with AIDS has been reported to range between 28% and 73% ¹. Historically, CVD was less common in this population due to the shorter survival rates associated with untreated HIV. However, as ART has dramatically improved survival, the long-term impact of HIV on the cardiovascular system is becoming increasingly apparent. People living with HIV still face an increased incidence of cardiovascular pathology ².

Pathogenesis of HIV-Associated Cardiovascular Disease

The development of CVD in HIV-infected individuals is multifactorial. Several factors contribute to this increased risk, including:

• Direct Viral Effects: HIV can directly infect cardiac cells, leading to inflammation and dysfunction.
• Chronic Inflammation: HIV infection is characterized by chronic immune activation and inflammation, even in individuals on ART. This chronic inflammation contributes to atherosclerosis and other cardiovascular complications.
• ART-Related Metabolic Abnormalities: Some ART regimens can cause metabolic disturbances, such as dyslipidemia (abnormal cholesterol levels) and insulin resistance, increasing the risk of CVD.
• Traditional Cardiovascular Risk Factors: Individuals with HIV often have a higher prevalence of traditional CVD risk factors, such as hypertension, smoking, and family history of heart disease.

Advances in cardiac imaging and immunology have deepened our understanding of the pathogenesis of HIV-associated CVD ².

Clinical Manifestations of CVD in HIV

HIV-infected individuals can develop a wide range of cardiovascular conditions, including:

• Coronary Artery Disease: The most common form of CVD, characterized by narrowing of the arteries supplying the heart.
• Heart Failure: A condition in which the heart cannot pump enough blood to meet the body’s needs.
• Cardiomyopathy: Disease of the heart muscle, which can lead to heart failure. Recent research highlights the significant link between HIV and cardiomyopathy, focusing on molecular mechanisms and clinical presentations ⁴.
• Arrhythmias: Irregular heartbeats.
• Valvular Heart Disease: Problems with the heart valves.
• Peripheral Artery Disease: Narrowing of the arteries in the limbs.

Diagnosis and Management

Diagnosing CVD in HIV-infected individuals requires a comprehensive evaluation, including a thorough medical history, physical examination, and appropriate diagnostic tests. These may include:

• Electrocardiogram (ECG): To assess heart rhythm.
• Echocardiogram: To evaluate heart structure and function.
• Stress Test: To assess blood flow to the heart during exercise.
• Coronary Angiography: To visualize the coronary arteries.
• Cardiac MRI: To provide detailed images of the heart.

Management of CVD in HIV-infected individuals involves a combination of lifestyle modifications, medical therapy, and, in some cases, interventional procedures. Key strategies include:

• Antiretroviral Therapy (ART): Maintaining viral suppression with ART is crucial.
• Management of Traditional Risk Factors: Controlling blood pressure, cholesterol, and blood sugar.
• Lifestyle Modifications: Adopting a healthy diet, exercising regularly, and quitting smoking.
• Pharmacological Therapy: Using medications to treat specific cardiovascular conditions.

The Evolving Landscape of HIV and CVD

As the HIV population continues to age, the burden of CVD is expected to increase. Ongoing research is focused on understanding the complex interplay between HIV, ART, and cardiovascular health, with the goal of developing more effective prevention and treatment strategies. The improved life expectancy of individuals with HIV has changed the paradigm regarding the long-term impact of the virus on the cardiovascular system ³.